Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

In diffuse large B-cell lymphoma (DLBCL), the Hans algorithm uses IHC markers to classify COO (cell of origin). Which panel correctly identifies germinal center B-cell (GCB) subtype?

  • A CD10- and MUM1+ regardless of BCL6 status
  • B CD10+ OR BCL6+ and MUM1-
  • C BCL2+ and MYC+ (double expresser)
  • D IRF4/MUM1+ and CD10-
Correct answer: B. CD10+ OR BCL6+ and MUM1-

Explanation

The Hans algorithm classifies DLBCL COO using CD10, BCL6, and MUM1 by IHC. GCB subtype is identified as CD10+ (regardless of others) OR CD10-/BCL6+/MUM1-. If CD10- and (BCL6- OR MUM1+), it is classified as activated B-cell (ABC) type. Double-expressor (BCL2+/MYC+) is a separate adverse prognostic category that can occur in either COO subtype. MUM1 (IRF4) positivity with CD10- is the ABC fingerprint.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →